Vaccinations-Reference-Cited by-同舟云学术

Vaccinations

Published:2024 Issue: Volume: Page:249-264
ISSN:
Container-title:The EBMT Handbook
language:en
Short-container-title:

Author:

de la Cámara Rafael,Meisel Roland

Abstract

AbstractVaccination should be considered a routine practice for all HCT receptors, either autologous or allogeneic, adults or children. It should be implemented in all HCT programs. Adult cover is particularly important as they represent 90% of HCTs.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-44080-9_29

Reference34 articles.

1. Armenian SH, Sun CL, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation (HCT) survivors: role in development of subsequent cardiovascular disease. Blood. 2012;120:4505–12.

2. Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, Lopez-Jimenez J, et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized clinical trial. JAMA. 2019;322(2):123–33.

3. Beck CR, McKenzie BC, Hashim AB, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by aetiology. J Infect Dis. 2012;206:1250–9.

4. Cesaro S, Ljungman P, Mikulska M, Hirsch HH, von Lilienfeld-Toal M, Cordonnier C, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36(6):1467–80.

5. Cesaro S, Mikulska M, Hirsh H, Styczynski J, Meylan S, Cordonnier C, et al. Update of recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2022 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2023;37(9):1933–8.